Company: MLSS
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001437749-25-026919
Chunk: 6

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 6
---
 and Hedging.

9.

Milestone Scientific presents “basic” earnings (loss) per common share applicable to common stockholders and, if applicable, “diluted” earnings (loss) per common share applicable to common stockholders pursuant to the provisions of ASC260,“ Earnings per Share”. Basic earnings (loss) per common share is calculated by dividing net income or loss applicable to common stockholders by the weighted average number of common shares outstanding and to be issued common shares as follows: 82,049,984and81,903,323for the threeand sixmonths ended June 30, 2025and79,966,833and80,412,397for the threeand sixmonths ended June 30, 2024respectively. The calculation of diluted earnings per common share is like that of basic earnings per common share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if all potentially dilutive common shares, such as those issuable upon the exercise of stock options, were issued during the period. Since Milestone Scientific had net losses in the sixmonths ended June 30, 2025and2024, the assumed effects of the exercise of potentially dilutive outstanding stock options, unissued restricted stock awards (“ RSA”), and convertible notes payable, related parties, were notincluded in the calculation as their effect would have been anti-dilutive. Such outstanding options, convertible notes payable, and RSA's totaled3,792,211and3,128,652for sixmonths ended June 30, 2025and2024, respectively.

10. Recent Accounting Pronouncements

Recently Issued Accounting Pronouncement

In November 2024, the Financial Accounting Standards Board, “ FASB”, issued Accounting Standards Update “ ASU”2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220 40, to improve the disaggregation of expenses within the consolidated statement of operations. The amendments in ASU2024-03require disclosures, in the notes to the consolidated financial statements, specified information about certain costs and expenses. The amendments require that at each interim and annual reporting period an entity disclose (a) employee compensation, (b) depreciation, and (c) intangible asset amortization included in each relevant expense caption; include certain amounts that are already required to be disclosed under current generally accepted accounting principles (GAAP) in the same disclosure as the other disaggregation requirements; and disclose a qualitative